Stephen Clarke
University of Sydney(AU)Cornell University(US)Royal North Shore Hospital(AU)Genesis HealthCare(US)Incom (United States)(US)Willows Veterinary Centre and Referral Service(GB)Weill Cornell Medicine(US)Bank of England(GB)Carnegie Mellon University(US)
Publications by Year
Research Areas
Colorectal Cancer Treatments and Studies, Lung Cancer Treatments and Mutations, Cancer Treatment and Pharmacology, Lung Cancer Research Studies, Cancer Genomics and Diagnostics
Most-Cited Works
- → Bevacizumab in Combination With Oxaliplatin-Based Chemotherapy As First-Line Therapy in Metastatic Colorectal Cancer: A Randomized Phase III Study(2008)2,958 cited
- → Cancer-related inflammation and treatment effectiveness(2014)2,136 cited
- → The systemic inflammation-based neutrophil–lymphocyte ratio: Experience in patients with cancer(2013)1,502 cited
- → Randomized Phase III Study of Capecitabine Plus Oxaliplatin Compared With Fluorouracil/Folinic Acid Plus Oxaliplatin As First-Line Therapy for Metastatic Colorectal Cancer(2008)863 cited
- → Safety and activity of microRNA-loaded minicells in patients with recurrent malignant pleural mesothelioma: a first-in-man, phase 1, open-label, dose-escalation study(2017)692 cited
- → Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial